STOXX 600Health Care· Switzerland

LONN

Status-Quo-Player

Lonza Group

$533.80

+0.91%

Open $530.00·Prev $529.00

Delayed

STATUS-QUO-PLAYER

Power Core

Lonza's moat is regulatory-validated manufacturing capacity for complex biologics, where switching costs compound over the lifetime of each drug product.

Published15 Apr 2026

UniverseSTOXX 600

SectorHealth Care

↑

Direction of Movement

upward

Financials